enow.com Web Search

  1. Ads

    related to: psa 5.5 for prostate cancer survival rate

Search results

  1. Results from the WOW.Com Content Network
  2. Prostate-specific antigen - Wikipedia

    en.wikipedia.org/wiki/Prostate-specific_antigen

    However, the PSA rate of rise may have value in prostate cancer prognosis. Men with prostate cancer whose PSA level increased by more than 2.0 ng per milliliter during the year before the diagnosis of prostate cancer have a higher risk of death from prostate cancer despite undergoing radical prostatectomy. [62]

  3. Prostate brachytherapy - Wikipedia

    en.wikipedia.org/wiki/Prostate_brachytherapy

    LDR prostate brachytherapy on its own has been shown to be highly effective for the treatment of early prostate cancer. [14] The rate of survival with no increase in average PSA levels after LDR brachytherapy is similar to that achieved with external beam radiotherapy and radical prostatectomy. [4]

  4. Comparison of bicalutamide with other antiandrogens

    en.wikipedia.org/wiki/Comparison_of_bicalutamide...

    6.5: 5.4 Hyperglycemia: 6.5: 6.6 ... study to prolong survival in prostate cancer to a greater ... monotherapy for prostate cancer had a greater risk of treatment ...

  5. Prostate cancer - Wikipedia

    en.wikipedia.org/wiki/Prostate_cancer

    Prostate cancer is a major topic of ongoing research. From 2016–2020, over $1.26 billion was invested in prostate cancer research, representing around 5% of global cancer research funds. [123] This places prostate cancer 10th among 18 common cancer types in funding per cancer death, and 9th in funding per disability-adjusted life year lost. [124]

  6. Thymidine kinase in clinical chemistry - Wikipedia

    en.wikipedia.org/wiki/Thymidine_kinase_in...

    Thymidine kinase has been suggested as a supplement to PSA (prostate-specific antigen), the tumor marker most frequently used in prostate cancer. Whereas PSA is considered to give an indication of the tumor mass, thymidine kinase activity indicates the rate of proliferation and the markers thus supplement each other. [85] [86] [87] [88]

  7. Flutamide - Wikipedia

    en.wikipedia.org/wiki/Flutamide

    Flutamide, sold under the brand name Eulexin among others, is a nonsteroidal antiandrogen (NSAA) which is used primarily to treat prostate cancer. [9] [10] It is also used in the treatment of androgen-dependent conditions like acne, excessive hair growth, and high androgen levels in women. [11]

  1. Ads

    related to: psa 5.5 for prostate cancer survival rate